DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ shed 2.25% to $814.79 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.02% to 7,675.70 and Dow Jones Industrial Average falling 0.21% to 53,463.88.
Regeneron Pharmaceuticals Inc. closed 3.80% short of its 52-week high of $847.00, which the company reached on August 21st.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. $(AMGN)$ fell 0.43% to $440.34, Moderna Inc. (MRNA) fell 5.77% to $149.66, and Gilead Sciences Inc. (GILD) fell 0.46% to $148.09.
Trading volume (583,019) remained 280,671 below its 50-day average volume of 863,690.
Data source: Dow Jones Market Data, FactSet. Data compiled August 26, 2026.
Comments